Alphagan patent ruling
Executive Summary
Allergan's lawsuit for induced infringement against Alcon and Bausch & Lomb was properly dismissed because the two companies' ANDAs for brimonidine did not seek FDA approval for uses claimed in two Allergan patents, U.S. appeals court rules March 28 (1"The Pink Sheet" Jan. 27, p. 18)...